Page last updated: 2024-08-17

edetic acid and Bone Marrow Diseases

edetic acid has been researched along with Bone Marrow Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmadzadehfar, H; Essler, M; Gaertner, F; Schlenkhoff, CD; Schmidt, M1
Cheung, L; Gano, J; Kavanagh, JJ; Kudelka, AP; Murray, JL; Rosenblum, MG; Verschraegen, CF1
Albahary, C1

Reviews

1 review(s) available for edetic acid and Bone Marrow Diseases

ArticleYear
Lead and hemopoiesis. The mechanism and consequences of the erythropathy of occupational lead poisoning.
    The American journal of medicine, 1972, Volume: 52, Issue:3

    Topics: Anemia; Bone Marrow Diseases; Cell Membrane; Cell Survival; Child; Edetic Acid; Erythrocytes; Erythrocytes, Abnormal; Erythropoiesis; Hematologic Diseases; Hematopoiesis; Heme; Hemoglobinopathies; Humans; Iron; Lead; Lead Poisoning; Mitochondria; Occupational Diseases; Osmotic Fragility; Penicillamine; Porphyrias; Porphyrins; Reticulocytes

1972

Trials

1 trial(s) available for edetic acid and Bone Marrow Diseases

ArticleYear
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:5

    Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Ascites; Ascitic Fluid; Bone and Bones; Bone Marrow; Bone Marrow Diseases; Carcinoma; Chelating Agents; Chelation Therapy; Dose-Response Relationship, Immunologic; Dose-Response Relationship, Radiation; Edetic Acid; Fallopian Tube Neoplasms; Female; Glycoproteins; Half-Life; Humans; Injections, Intraperitoneal; Mice; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Injuries; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Tissue Distribution; Treatment Outcome; Ytterbium

1999

Other Studies

1 other study(ies) available for edetic acid and Bone Marrow Diseases

ArticleYear
Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:6

    Topics: Aged; Anemia; Antineoplastic Agents; Bone Marrow Diseases; Bone Neoplasms; Compassionate Use Trials; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium; Technetium Tc 99m Medronate

2016